Press Releases 2015
New clinical trial data assessing the Boston Scientific Lotus™ Valve System continue to support strong performance and safety profile - Sep 22, 2015
Results from clinical trials evaluating the Boston Scientific (NYSE: BSX) Lotus™ Valve System continue to show this advanced transcatheter aortic valve implantation (TAVI) therapy ...
Boston Scientific announces CE mark and FDA clearance for the Safari2™ Pre-Shaped Guidewire - July 22, 2015
Boston Scientific (NYSE: BSX) announces CE Mark and FDA clearance for the Safari2™ Pre-Shaped Guidewire, a new and enhanced version of the Safari Guidewire, ...
Post-market study evaluating the LOTUS™ Valve System demonstrates extremely low PVL rates - May 20, 2015
A new study evaluating the Boston Scientific (NYSE: BSX) Lotus™ Valve System demonstrated an extremely low rate of paravalvular aortic regurgitation (leakage) for a transcatheter aortic replacement valve ...
Media Contacts
Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com